Skip to main content
Duke University Libraries
Search 
  •   DukeSpace
  • Duke Scholarly Works
  • Search
  •   DukeSpace
  • Duke Scholarly Works
  • Search
    • Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-6 of 6

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Economics of new oncology drug development. 

    DiMasi, Joseph A; Grabowski, Henry G (J Clin Oncol, 2007-01-10)
    PURPOSE: Review existing studies and provide new results on the development, regulatory, and market aspects of new oncology drug development. METHODS: We utilized data from the US Food and Drug Administration (FDA), company ...
    Thumbnail

    R&D costs and returns by therapeutic category 

    DiMasi, Joseph A; Grabowski, Henry G; Vernon, John M (Drug Information Journal, 2004-09-03)
    Objectives: This study examines the degree to which therapeutic class accounts for variability in drug development costs. It also scrutinizes how sales levels vary across the associated therapeutic classes for those drugs ...
    Thumbnail

    Should the patent system for new medicines be abolished? 

    DiMasi, Joseph A; Grabowski, Henry G (Clin Pharmacol Ther, 2007-11)
    Thumbnail

    The cost of biopharmaceutical R&D: Is biotech different? 

    DiMasi, Joseph A; Grabowski, Henry G (Managerial and Decision Economics, 2007-06-01)
    The costs of developing the types of new drugs that have been pursued by traditional pharmaceutical firms have been estimated in a number of studies. However, similar analyses have not been published on the costs of developing ...
    Thumbnail

    The price of innovation: new estimates of drug development costs. 

    DiMasi, Joseph A; Grabowski, Henry G; Hansen, Ronald W (J Health Econ, 2003-03)
    The research and development costs of 68 randomly selected new drugs were obtained from a survey of 10 pharmaceutical firms. These data were used to estimate the average pre-tax cost of new drug development. The costs of ...
    Thumbnail

    Returns on R&D for 1990s New Drug Introductions 

    DiMasi, Joseph A; Grabowski, Henry G; Vernon, John M (PharmacoEconomics, 2002)
     

     

    Browse

    All of DukeSpaceCommunities & CollectionsAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit DateThis CommunityAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit Date

    My Account

    LoginRegister

    Discover

    Author
    DiMasi, Joseph A (6)
    Grabowski, Henry G (6)
    Vernon, John M (2)Hansen, Ronald W (1)Date Issued2007 (3)2002 (1)2003 (1)2004 (1)TypeJournal article (6)SubjectDrug Industry (3)Humans (3)Drug Approval (2)Drug Costs (2)United States (2)Antineoplastic Agents (1)Biomedical Research (1)Capital Expenditures (1)Commerce (1)Cost-Benefit Analysis (1)... View MoreAffiliation of Duke Author(s)
    Duke (6)
    Economics (6)
    Trinity College of Arts & Sciences (6)